Living DNA and its partners are aiming to create a detailed genetic map of the world based on people's DNA.
With the rollout of Insitome's first app, consumers have the chance to explore their heritage in a new context that could reshape the ancestry testing market.
The company has developed a suite of initial products focused on ancestry that will compete with offerings from 23andMe, AncestryDNA, and Family Tree DNA.
At the Guardian, Samantha Gillison writes that she took a DNA ancestry test and found she was exactly what she thought she was.
A recent study examining the websites of 30 DTC genomics firms found that many do not follow international recommendations for disclosing information to customers.
The company said the investments will support growth in its AncestryDNA genetic genealogy offering.
Consumer genetics companies field law enforcement requests, the Associated Press reports.
At the New York Times, Marie Tae McDermott writes about her experience with genetic testing as an adoptee.
Researchers from Brigham and Women's and Harvard surveyed more than 1,600 new customers of 23andMe or Pathway Genomics in the US, of whom 80 were adopted.
In PLOS this week: researchers trace inherited cancer syndrome to a German couple born in the 1700s, loci involved in exceptional longevity, and more.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.